Human Gene Therapy

SJR Rank #3,229H-index: 167SJR: 1.282Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Mary Ann Liebert Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • GeneticsQ1
  • Molecular BiologyQ2
  • Molecular MedicineQ2

Areas: Biochemistry, Genetics and Molecular Biology

Most published research topics

Virus-based gene therapy researchCRISPR and Genetic EngineeringRNA Interference and Gene DeliveryCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsBiomedical Ethics and RegulationImmunotherapy and Immune ResponsesViral gastroenteritis research and epidemiologyCancer Research and TreatmentsAnimal Genetics and Reproduction

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs090180270360

Documents per Year

2022202503570105140

Detailed Information

ISSN

1043-0342, 1557-7422

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

3.78

References per Document

47.80

Coverage

1990-2026

Scope

Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies. Established in 1990, HGT provides a prestigious forum for publishing scientific and clinical research, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

Metrics from SCImago Journal Rank 2025. View on SCImago